Tag: market entry delay

Tentative Approval and Litigation: Navigating the Path to Generic Drug Market Entry

Tentative approval from the FDA lets generic drug makers prepare for market entry while patents are still active. But missing deadlines or mismanaging litigation can cost millions. Here’s how to navigate the system and avoid costly delays.